| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.016 | 9.785 | 9.657 | 9.351 | 8.597 | 16.740 | 33.149 | 33.959 | 34.385 | 31.695 |
| Total Income - EUR | 11.017 | 9.788 | 9.659 | 9.354 | 8.635 | 16.741 | 33.157 | 33.969 | 34.389 | 31.699 |
| Total Expenses - EUR | 7.853 | 5.876 | 7.489 | 8.385 | 11.079 | 10.159 | 10.079 | 17.318 | 19.112 | 20.650 |
| Gross Profit/Loss - EUR | 3.164 | 3.911 | 2.170 | 970 | -2.444 | 6.582 | 23.078 | 16.651 | 15.277 | 11.049 |
| Net Profit/Loss - EUR | 2.834 | 3.716 | 2.074 | 876 | -2.529 | 6.423 | 22.753 | 16.318 | 14.940 | 10.738 |
| Employees | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pharm Vet Fancy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 1.438 | 1.150 | 10.923 | 7.125 | 4.501 |
| Current Assets | 1.869 | 3.814 | 5.943 | 6.759 | 3.863 | 9.029 | 27.735 | 8.055 | 9.541 | 8.305 |
| Inventories | 127 | 127 | 103 | 189 | 185 | 157 | 154 | 95 | 0 | 0 |
| Receivables | 71 | 71 | 279 | 68 | 67 | 2.133 | 7.779 | 2.433 | 2.878 | 2.902 |
| Cash | 1.671 | 3.616 | 5.561 | 6.502 | 3.611 | 6.739 | 19.802 | 5.526 | 6.662 | 5.403 |
| Shareholders Funds | -749 | 2.975 | 4.997 | 5.782 | 3.141 | 9.504 | 27.791 | 16.367 | 14.988 | 10.786 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.618 | 839 | 946 | 978 | 723 | 962 | 1.094 | 2.611 | 1.677 | 2.019 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Pharm Vet Fancy Srl